Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Masonic Cancer Center, University of Minnesota"
Count: 268
Selected: 0
NCT IDTitle
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT03365661QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
NCT05708703Assessing the Time Demands of Cancer
NCT04228952Metabolism of NNK in Japanese Americans
NCT01158456Metabolism of NNK Among African Americans
NCT03978117Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens
NCT04630769FT516 and IL2 With Enoblituzumab for Ovarian Cancer
NCT05502302App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer
NCT04969783Telehealth-Filter Ventilation ( COMET2P1 )
NCT05735717MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
NCT02605421Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT06030648MT2022-01: MSCs for ALD
NCT03678493A Study of FMT in Patients With AML Allo HSCT in Recipients
NCT05447156QuitGuide for American Indians: Aims 2 & 3
NCT04714372FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
NCT05363267NF-1, Nutraceutical Intervention
NCT03557749Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT05973656Role of Acetaldehyde in the Development of Oral Cancer
NCT05700630Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
NCT04003805Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
NCT02582775MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
NCT05338658Study of PAT in Patients With Solid Tumor Cancers
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT05025774Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
NCT04855253Study of E7777 Prior to Kymriah for R/R DLBCL
NCT03674411Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
NCT05665543Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NCT03850691Radiation and Combination Immunotherapy for Melanoma
NCT05123040Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
NCT03998735Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure
NCT03367546Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT02670837Study of Cellutome System for Treatment of Individual Lesions in EB Pts
NCT00167219Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT02666105Exemestane in Post-Menopausal Women With NSCLC
NCT03946423BAriaTric Surgery After Breast Cancer Treatment (BATS)
NCT03417154Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
NCT02988466Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
NCT05805605Allo HSCT Using RIC and PTCy for Hematological Diseases
NCT03054909IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
NCT05708924MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT03789721Adrenoleukodystrophy National Registry Study
NCT05114837Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
NCT04882423Vegetable Intake Effect on Heterocyclic Amine Metabolism
NCT05322408HCW9218 in Select Advanced Solid Tumors
NCT05120570PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
NCT03934840CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders